Back to
FARALLON CAPITAL MANAGEMENT, L.L.C.
CRSP10 quarters
Position history for
FARALLON CAPITAL MANAGEMENT, L.L.C.'s holdings in CRISPR THERAPEUTICS AG
FARALLON CAPITAL MANAGEMENT, L.L.C. previously held 0 shares of CRSP (CRISPR THERAPEUTICS AG), worth $0 as of 2024-Q3.
Final Value
$0
Final Shares
0
Total Value Change
-$35.7M
Total Shares Change
-1.3M
Quarter-by-Quarter History
Other major holders of CRSP: ARK Investment Management LLC, Capital International Investors